Nomura Asset Management Co. Ltd. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 112.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,497 shares of the company’s stock after buying an additional 6,083 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $8,334,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Acropolis Investment Management LLC purchased a new position in Intuitive Surgical during the third quarter valued at approximately $109,000. Global X Management Co. LLC bought a new stake in Intuitive Surgical during the second quarter valued at about $118,000. Bartlett & Co. LLC increased its stake in Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock valued at $146,000 after buying an additional 15 shares in the last quarter. Stephens Inc. AR increased its stake in Intuitive Surgical by 77.1% in the third quarter. Stephens Inc. AR now owns 255 shares of the company’s stock valued at $185,000 after buying an additional 111 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its stake in Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock valued at $181,000 after buying an additional 8 shares in the last quarter. Institutional investors and hedge funds own 90.53% of the company’s stock.
Intuitive Surgical, Inc. (NASDAQ:ISRG) traded up 2.33% on Wednesday, reaching $677.65. The company had a trading volume of 257,127 shares. Intuitive Surgical, Inc. has a 12-month low of $502.01 and a 12-month high of $727.25. The stock has a market capitalization of $26.26 billion, a PE ratio of 36.55 and a beta of 0.52. The stock’s 50 day moving average price is $637.73 and its 200-day moving average price is $672.81.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 18th. The company reported $6.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $5.13 by $1.06. The business had revenue of $682.90 million for the quarter, compared to analysts’ expectations of $650.49 million. Intuitive Surgical had a net margin of 27.51% and a return on equity of 15.02%. The company’s revenue was up 15.8% compared to the same quarter last year. During the same quarter last year, the company posted $5.24 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post $22.19 earnings per share for the current fiscal year.
ISRG has been the topic of several recent research reports. Barclays PLC restated an “overweight” rating and set a $760.00 target price (up previously from $750.00) on shares of Intuitive Surgical in a research report on Friday, October 21st. Royal Bank Of Canada increased their target price on Intuitive Surgical from $750.00 to $760.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 19th. Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, September 20th. Wedbush restated an “outperform” rating and set a $755.00 target price (down previously from $785.00) on shares of Intuitive Surgical in a research report on Wednesday, October 19th. Finally, Wells Fargo & Company initiated coverage on Intuitive Surgical in a research report on Thursday, October 13th. They set an “outperform” rating on the stock. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $729.16.
In other news, Director Lonnie M. Smith sold 275 shares of Intuitive Surgical stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $646.50, for a total transaction of $177,787.50. Following the transaction, the director now owns 235,890 shares in the company, valued at approximately $152,502,885. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 13,515 shares of Intuitive Surgical stock in a transaction on Monday, November 7th. The stock was sold at an average price of $680.68, for a total transaction of $9,199,390.20. Following the transaction, the chief executive officer now owns 82,880 shares in the company, valued at approximately $56,414,758.40. The disclosure for this sale can be found here. Insiders own 3.10% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
What are top analysts saying about Intuitive Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intuitive Surgical Inc. and related companies.